EUDA Health Holdings Ltd. Files July 2024 6-K Report
Ticker: EUDAW · Form: 6-K · Filed: Jul 3, 2024 · CIK: 1847846
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-update
TL;DR
EUDA Health Holdings Ltd. (formerly 8i Acquisition 2 Corp.) filed its July 6-K, standard foreign issuer report.
AI Summary
EUDA Health Holdings Ltd. filed a Form 6-K on July 3, 2024, reporting for the month of July 2024. The company, formerly known as 8i Acquisition 2 Corp. until February 24, 2021, is based in Singapore and operates in the health services sector. This filing is a routine report of a foreign private issuer.
Why It Matters
This filing provides routine updates for investors and regulators regarding EUDA Health Holdings Ltd.'s status as a foreign private issuer, offering transparency into its ongoing reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain specific financial or operational disclosures that would indicate immediate risk.
Key Players & Entities
- EUDA Health Holdings Ltd (company) — Registrant
- 8i Acquisition 2 Corp. (company) — Former company name
- July 3, 2024 (date) — Filing date
- July 2024 (date) — Reporting period
- February 24, 2021 (date) — Date of name change
- Singapore (location) — Company location
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of July 2024, as EUDA Health Holdings Ltd. is a foreign private issuer.
What was EUDA Health Holdings Ltd.'s former name?
EUDA Health Holdings Ltd.'s former name was 8i Acquisition 2 Corp., with the name change occurring on February 24, 2021.
Where is EUDA Health Holdings Ltd. located?
EUDA Health Holdings Ltd. is located at 1 Pemimpin Drive #12-07, One Pemimpin, Singapore 576151.
What is the SEC file number for EUDA Health Holdings Ltd.?
The SEC file number for EUDA Health Holdings Ltd. is 001-40678.
Does EUDA Health Holdings Ltd. file annual reports under Form 20-F?
Yes, the filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
Filing Stats: 731 words · 3 min read · ~2 pages · Grade level 15.7 · Accepted 2024-07-03 08:30:27
Key Financial Figures
- $15.0 million — hares”) of the Company, valued at $15.0 million based on a per share price of $1.50 of
- $1.50 — 0 million based on a per share price of $1.50 of EUDA’s ordinary shares. On M
- $1.75 — ice of EUDA’s ordinary shares was $1.75 per share, and parties agreed that the
Filing Documents
- form6-k.htm (6-K) — 21KB
- ex10-1.htm (EX-10.1) — 13KB
- ex10-1_001.jpg (GRAPHIC) — 54KB
- ex10-1_002.jpg (GRAPHIC) — 69KB
- ex10-1_003.jpg (GRAPHIC) — 361KB
- ex10-1_004.jpg (GRAPHIC) — 408KB
- ex10-1_005.jpg (GRAPHIC) — 407KB
- ex10-1_006.jpg (GRAPHIC) — 257KB
- ex10-1_007.jpg (GRAPHIC) — 70KB
- ex10-1_008.jpg (GRAPHIC) — 43KB
- ex10-1_009.jpg (GRAPHIC) — 41KB
- ex10-1_010.jpg (GRAPHIC) — 43KB
- ex10-1_011.jpg (GRAPHIC) — 42KB
- ex10-1_012.jpg (GRAPHIC) — 57KB
- ex10-1_013.jpg (GRAPHIC) — 87KB
- 0001493152-24-026137.txt ( ) — 2707KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: July 3, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer